Redemption Psychiatry
Redemption Psychiatry is a physician-owned outpatient psychiatric practice in the Phoenix metro area offering medication management, TMS, ketamine therapy, ADHD testing, and Deep Brain Stimulation for OCD to children, adolescents, and adults across five Arizona locations.
- Company typePrivate
- Founded2013
- HeadquartersGilbert, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Redemption Psychiatry does
Redemption Psychiatry LLC is a physician-owned outpatient psychiatric practice headquartered in Gilbert, Arizona, founded in 2013 by Dr. Jason Friday. It operates five clinical locations across the Phoenix metropolitan area (Gilbert, Mesa, Phoenix, and two Chandler sites) and employs 51–100 staff including 37+ clinical providers (psychiatrists, DNPs, PMHNPs, and PAs). The practice delivers multi-modal psychiatric care to children, adolescents, and adults, including medication management, ADHD and cognitive testing, Transcranial Magnetic Stimulation (TMS), ketamine therapy in IV, IM, and Spravato (esketamine) nasal spray forms, Ketamine-Assisted Therapy (KAT), and Deep Brain Stimulation (DBS) for treatment-resistant OCD — the last delivered in partnership with neurosurgery at Barrow Neurological Institute.
The technology stack is anchored in neuromodulation hardware (TMS equipment with 3D neuro-navigation for coil placement and theta burst stimulation protocols), ketamine delivery infrastructure (IV infusion, IM injection, and supervised Spravato administration), and a third-party cognitive testing integration with Creyos for objective ADHD diagnosis. Revenue is generated through a hybrid insurance-and-self-pay model: most services are covered by major commercial insurers (subject to prior authorization), while self-pay rates are positioned meaningfully below Phoenix market averages (TMS $2,500 per full course versus a $5,000–$12,500 market range; ketamine at $250 per session after a probono first infusion; ADHD testing at $150 cash-pay). Advanced services are housed under a sub-brand, Revolution Treatments, and the practice runs a Community Heroes discount program for first responders, medical professionals, and military personnel. Patients access care through in-person visits, telehealth, an online new-patient intake form, phone/text, and a Valant-hosted patient portal.
The go-to-market combines direct-to-consumer acquisition (website intake, phone/text) with provider referrals from therapists, primary care physicians, and specialists. The practice excludes Medicare and Medicaid, narrowing its addressable payer pool but allowing below-market cash pricing and commercial-insurance throughput. Customer segments span adults with mood, anxiety, OCD, PTSD, and ADHD, treatment-resistant populations, and a dedicated first-responder/military cohort; quantifiable clinical outcomes cited include roughly two-thirds TMS symptom reduction and one-third remission in depression cohorts, 70% ketamine effectiveness rising to 80–90% when combined with other treatments, and a 61.5% DBS responder rate.
Redemption Psychiatry firmographics
Firmographics- Name
- Redemption Psychiatry
- Legal name
- Redemption Psychiatry LLC
- Website
- https://redemptionpsychiatry.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Redemption Psychiatry is a physician-owned outpatient psychiatric practice in the Phoenix metro area offering medication management, TMS, ketamine therapy, ADHD testing, and Deep Brain Stimulation for OCD to children, adolescents, and adults across five Arizona locations.
- Ownership category
- akta.pro rank
Redemption Psychiatry industry classification
Industry- Product category
- Outpatient Psychiatric Services
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142), Offices of Physicians, Mental Health Specialists (621112)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)
- akta.pro secondary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
Keywords
Where Redemption Psychiatry is headquartered
LocationHeadquarters
- HQ city
- Gilbert
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Redemption Psychiatry business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Medication Management Services: Ongoing psychiatric medication management including evaluations, prescriptions, adjustments, and follow-ups. Billed through insurance or self-pay. Accepts all major health insurances.
- TMS Therapy: Transcranial Magnetic Stimulation for treatment-resistant depression and OCD. Revenue from insurance reimbursement and self-pay ($2,500 full course). Most insurances cover TMS for depression.
- Ketamine Treatments: IV, IM, and Spravato ketamine treatments. First IV infusion is probono. Subsequent treatments at $250 each or $1,250 for initial 6-session series. IM often covered by insurance. Spravato requires prior authorization.
- ADHD and Cognitive Testing: Diagnostic testing using Creyos platform. Covered by most major insurance carriers. $150 cash-pay rate for those not covered, with additional discounts for qualifying patients.
- Deep Brain Stimulation for OCD: Surgical treatment for treatment-resistant OCD. Involves device implantation. Revenue through insurance with prior authorization requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | TMS Self-Pay Full Course: $2,500 |
| Unit Pricing | Pay-as-you-go | Ketamine IV: First Treatment FREE, Subsequent $250/session |
| Unit Pricing | Pay-as-you-go | Ketamine IM: $250/session (often $0 with insurance) |
| Subscription | Monthly | Spravato (Esketamine) Nasal Spray: Insurance covered with PA |
| Unit Pricing | One time/ perpetual license | ADHD/Cognitive Testing: $150 self-pay (insurance covered) |
| Other | Pay-as-you-go | Community Heroes Discount Program |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Redemption Psychiatry product offering
Product offeringCore offering
Redemption Psychiatry is a physician-owned outpatient psychiatric practice providing comprehensive mental health care including psychiatric medication management, FDA-approved Transcranial Magnetic Stimulation (TMS) for depression and OCD, IV/IM/Spravato ketamine therapy, Ketamine-Assisted Psychotherapy (KAT), ADHD and cognitive testing, and Deep Brain Stimulation (DBS) for treatment-resistant OCD. The practice serves children, adolescents, and adults across the Phoenix metro area through in-person visits at five Arizona locations and telehealth.
Product overview
Redemption Psychiatry is a physician-owned outpatient psychiatric practice offering a multi-modal suite of mental health treatments spanning medication management and advanced neuromodulation therapies. The core portfolio includes psychiatric medication management (evaluations, prescriptions, and follow-ups), several forms of ketamine treatment (IV, IM, and Spravato® nasal spray), Transcranial Magnetic Stimulation (TMS) therapy for depression and OCD (including an autism-specific protocol), ADHD and cognitive testing via the Creyos platform, Deep Brain Stimulation (DBS) for treatment-resistant OCD, and Ketamine-Assisted Psychotherapy (KAT). TMS and ketamine services are delivered in partnership with Revolution Treatments. The practice serves children, adolescents, and adults across Arizona with in-person and telehealth options.
Differentiator
Problem solved
Functional benefit
Brands
- Revolution Treatments: An advanced treatment team that works with Redemption Psychiatry, providing TMS and ketamine treatments. Patients are scheduled with Revolution Treatments for their advanced psychiatric treatments including ketamine, TMS, and other treatment options.
Products and services
- Medication Management
Quantifiable outcome
- Approximately 50-60% of patients with treatment-resistant depression improve significantly with TMS therapy, with about one-third achieving full remission
- +5 more outcomes
Companies that use Redemption Psychiatry
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles5 records
Redemption Psychiatry technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature5 records
Redemption Psychiatry partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- Revolution TreatmentscoreRevolution Treatments is an advanced treatment team that works with Redemption Psychiatry for TMS and ketamine treatments. Providers review medication history and discuss ketamine, TMS, and other treatment options with patients. Located at 4920 S Alma School Rd Suite 3, Chandler, AZ 85248.
- CreyossupportingPartnership with Creyos testing system for ADHD and cognitive disorder diagnosis. Creyos delivers interactive, game-like tests analyzing reaction times, error tendencies, and spatial reasoning under pressure to generate diagnostic reports for providers.
- Dr. Ponce (Barrow Neurological Institute)coreNeurosurgeon Dr. Ponce at Barrow Neurological Institute performs DBS lead placement and battery implantation surgeries. Redemption refers appropriate DBS candidates for surgical consultation and works with the neurosurgeon for ongoing device programming.
Scale indicators4 records
Recent moves3 records
Expansion highlights6 records
Redemption Psychiatry competitors and assessment
Company assessmentOthers
- Axsome Therapeutics: Commercial-stage CNS pharmaceutical company marketing Auvelity for major depressive disorder. Not a direct service competitor but sells into the same physician-prescribed outpatient psychiatry channel that Redemption serves, with overlapping treatment-resistant patient populations.
- Neuronetics: Manufacturer of NeuroStar TMS systems used by Redemption Psychiatry. An enabling technology supplier rather than a service competitor, but materially comparable in that its installed base defines the structural addressable market of TMS clinics nationwide.
Direct peers
- Field Trip Health: Outpatient clinic chain offering ketamine-assisted psychotherapy with physician oversight and integrative mental health services. Highly comparable to Redemption's KAT and ketamine service lines in patient profile and clinical framing.
- Cerebral: Telehealth-first outpatient psychiatry/ADHD platform delivering medication management and counseling under insured and subscription models. Comparable in direct-to-consumer outpatient psychiatry GTM and ADHD testing emphasis, differentiated by virtual-only delivery.
- Numinus Wellness: Clinical operator of ketamine-assisted therapy and psychedelic-medicine clinics in the US and Canada, including acquired Novamind clinics. Directly comparable in ketamine/Spravato service lines and physician-supervised outpatient delivery for treatment-resistant mental health.
- Mindful Health Solutions: Multi-location psychiatric practice in California offering medication management, TMS, ketamine (Spravato and IV), and ADHD testing under physician-led care. Directly comparable to Redemption Psychiatry in service mix, advanced-treatment emphasis, and outpatient-specialty positioning.
- Talkiatry: National in-network online psychiatric practice delivering medication management by board-certified psychiatrists via telehealth. Comparable in physician-led outpatient psychiatry service model and in-network insurance positioning, though without advanced treatments.
- Greenbrook TMS NeuroHealth: Public multi-site operator of TMS centers for depression and OCD, with physician-supervised medical management. Comparable in TMS-centric service model and multi-state clinic footprint, though more focused on TMS and less on ketamine/DBS breadth.
- Ketamine Clinics of Los Angeles: Outpatient psychiatric practice specializing in IV ketamine and ketamine-assisted therapy for depression, anxiety, and PTSD. Directly comparable to Redemption's IV/IM ketamine and KAT offerings and treatment-resistant patient segment.
Broad incumbents
- Amen Clinics: Multi-clinic brain-focused psychiatry network combining imaging-based diagnostics (SPECT), medication management, and intensive outpatient programs. Comparable in physician-led outpatient psychiatry and neurocognitive assessment orientation, broader in scale and brand than Redemption.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Redemption Psychiatry social profiles
Digital presenceRedemption Psychiatry financial estimates
Financial estimateRevenue estimate
Valuation estimate
Redemption Psychiatry leadership team
Management profileNumber of profiles
Profiles1 record
Redemption Psychiatry subsidiaries and ownership
Company hierarchySubsidiaries1 record
Redemption Psychiatry funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Redemption Psychiatry M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Redemption Psychiatry
What does Redemption Psychiatry do?
Redemption Psychiatry is a physician-owned outpatient psychiatric practice providing comprehensive mental health care including psychiatric medication management, FDA-approved Transcranial Magnetic Stimulation (TMS) for depression and OCD, IV/IM/Spravato ketamine therapy, Ketamine-Assisted Psychotherapy (KAT), ADHD and cognitive testing, and Deep Brain Stimulation (DBS) for treatment-resistant OCD. The practice serves children, adolescents, and adults across the Phoenix metro area through in-person visits at five Arizona locations and telehealth.
Is Redemption Psychiatry a public or private company?
Redemption Psychiatry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Redemption Psychiatry founded?
Redemption Psychiatry was founded in 2013. It employs 51 to 100 people.
Where is Redemption Psychiatry based?
Redemption Psychiatry is headquartered in Gilbert, United States, in the North America region.
How does Redemption Psychiatry make money?
Five revenue lines are on record. Medication Management Services are the primary driver. The others are TMS Therapy, ketamine Treatments, ADHD and Cognitive Testing and deep Brain Stimulation for OCD.
Who are Redemption Psychiatry's main competitors?
Others on record are Axsome Therapeutics and Neuronetics. Direct peers are Field Trip Health, Cerebral, Numinus Wellness, Mindful Health Solutions, Talkiatry, Greenbrook TMS NeuroHealth and Ketamine Clinics of Los Angeles. Amen Clinics is listed as a broad incumbent.
Does Redemption Psychiatry have an API?
No public API is recorded for Redemption Psychiatry.
What industry is Redemption Psychiatry in?
Redemption Psychiatry's product category is Outpatient Psychiatric Services. Its primary akta.pro industry code is HLAFACAA, Outpatient Mental Health Clinics & Counseling Centers, with a secondary code of HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 621420 and its SIC code is 8011.